IP Library › Granted Patent US 7,001,719
Granted Patent B2
US 7,001,719 · App. 10/818,092 · Granted Feb 21, 2006

Devices and methods for microorganism detection

Assignee: 3M Innovative Properties Company
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,001,719
App. No.
10/818,092
Granted
Feb 21, 2006
Kind
B2
Abstract

A device that includes at least two chambers separated by an activatable seal wherein upon activation of the seal the two chambers are in communication, and further wherein at least one chamber of the device includes a biological assay reagent and methods of using same.

Claims (11)

1. A method for detecting the presence or absence of bacteria, the method comprising:

providing a device comprising at least three chambers separated from each other by seals, wherein a first chamber includes bacteriophage, a second chamber includes an antiviral agent, and a third chamber includes bacterial helper cells, wherein the second chamber is disposed between the first and third chambers;

adding a sample suspected of including target bacteria to the first chamber comprising bacteriophage;

allowing the bacteriophage to infect the target bacteria;

activating the seal between the first and second chambers to allow contact between the antiviral agent and extracellular bacteriophage;

activating the seal between the second and third chambers to allow contact between the bacterial helper cells and the infected target bacteria;

incubating the bacterial helper cells and the infected bacteria; and

detecting the presence or absence of the target bacteria in the sample.

2. The method of claim 1 wherein the second chamber is separated into two subchambers separated from each other by a seal.

3. The method of claim 2 wherein the two subchambers of the second chamber each include an antiviral agent.

4. The method of claim 3 wherein the seal between the two subchambers is activated to allow the two antiviral agents to mix prior to contacting the antiviral agents with the extracellular bacteriophage.

Continuity (3)
Division 0943458600 · Nov 5, 1999
Provisional Application 6015723700 · Oct 1, 1999
Related Publication 20040191892A1 · Sep 30, 2004